Shire
Shire announces split into two business units, downgrades revenue forecast
January 9, 2018Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease
Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …
Pharmafile.com’s top ten stories of 2017
December 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit
After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …
Pharma carousel sees Bayer discovery chief head to Shire
December 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Shire, biotech, drugs, pharma, pharmaceutical
It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …
Shire to streamline operations with 100-strong plant sale and in-house Cinryze production
October 31, 2017Manufacturing and Production, Sales and Marketing Cinryze, Shire, pharma
Shire has revealed that it plans to sell one of its manufacturing sites in Milford, Massachusetts, having already entered active …
Shire takes fight to Allergan over dry-eye drug
October 4, 2017Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical
It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …
Shire submits dry-eye drug for marketing approval
August 15, 2017Manufacturing and Production, Sales and Marketing Shire, biotech, drugs, pharma, pharmaceutical
Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …
Shire shifts vaccine facility from Baxalta deal to MSD
August 8, 2017Manufacturing and Production Baxalta, MSD, Shire, biotech, drugs, pharma, pharmaceutical
As part of Shire’s mega-merger with Baxalta, it suddenly had a massive manufacturing network that spanned 17 sites across seven …
Shire and Roche haemophilia spat spills into court
July 10, 2017Sales and Marketing Roche, Shire, haemophilia
Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …
10 years later, Shire gains FDA approval for ADHD drug
June 21, 2017Research and Development, Sales and Marketing ADHD, Shire
Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …
Shire creates 150 jobs with Dublin HQ relocation
May 2, 2017Manufacturing and Production Dublin, Shire
Rare disease specialist Shire has opened the doors of its new headquarters in Dublin, Ireland. The pharma company has leased …
‘World Hemophilia Day’ marked by release of data
April 20, 2017Medical Communications, Research and Development Roche, Shire, haemophilia
‘World Hemophilia Day’ occurred on 17 April and the day was marked by the release of data from two companies …
NICE turns down Shire’s pancreatic cancer treatment
April 4, 2017Manufacturing and Production, Sales and Marketing NICE, Pancreatic cancer, Shire
NICE has announced its intention not to recommend the NHS use of Shire’s Onivyde (pegylated liposomal irinotecan) for the treatment …
Shire’s drug picked up from Baxalta given fast track designation
March 23, 2017Research and Development, Sales and Marketing Shire, rare diseases
Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …
Death in trial of Roche’s potential blockbuster haemophilia drug
February 24, 2017Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia
Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …
China’s insurance expansion boon to global pharma
February 23, 2017Sales and Marketing AstraZeneca, China, GSK, Shire
China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …
Latest content
